Document is current
Any future updates will be listed below
-
Authors
Charneca, Sofia
Hernando, Ana
Almada-Correia, Inês
Polido-Pereira, Joaquim
Vieira, Adriana
Sousa, Joana
Almeida, Ana Santos
Motta, Carla
Barreto, Gonçalo
Eklund, Kari K.
Alonso-Pérez, Ana
Gómez, Rodolfo
Cicci, Francesco
Mauro, Daniele
Pinho, Salomé S.
Fonseca, João Eurico
Costa-Reis, Patrícia
Guerreiro, Catarina Sousa
-
Funding
Funding for this research was provided by:
European Union's Horizon Europe research and innovation programme (101095084)
European Union's Horizon Europe research and innovation programme (101095084)
European Union's Horizon Europe research and innovation programme (101095084)
European Union's Horizon Europe research and innovation programme (101095084)
European Union's Horizon Europe research and innovation programme (101095084)
University of Helsinki
- License Information
-
More Information
Article History
Received: 8 December 2024
Accepted: 6 February 2025
First Online: 7 April 2025
Declarations
:
: This trial was approved by the ethics committee of Lisbon Academic Medical Centre, CAML (Ref. Nº114/22). The ethical norms and standard conduct rules specified in the Helsinki Declaration as modified and its later amendments, or comparable ethical standards, will be followed and respected. Participants sign a written informed consent form before any study procedures. All biologic samples will be coded and stored at the Biobank-GIMM, ensuring their safety and protection. Biobank-GIMM was approved by the ethics committee of CAML and by the National Data Protection Board [].
: Not applicable.
: The authors declare no competing interests.
